USPTO serial 75276164
LUMAXIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 31, 2001
- Examiner
- MICHOS, JOHN E
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LUMAXIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
DUPONT PHARMACEUTICALS COMPANY
WILMINGTON, DE
DUPONT PHARMACEUTICALS COMPANY
WILMINGTON, DE
DUPONT PHARMACEUTICALS COMPANY
WILMINGTON, DE
DUPONT PHARMACEUTICALS COMPANY
WILMINGTON, DE
DuPont Merck Pharmaceutical Company, The
Wilmington, DE
Other trademarks owned by DuPont Merck Pharmaceutical Company, The
DuPont Merck Pharmaceutical Company, The
Wilmington, DE
Other trademarks owned by DuPont Merck Pharmaceutical Company, The
DuPont Merck Pharmaceutical Company, The
Wilmington, DE
Other trademarks owned by DuPont Merck Pharmaceutical Company, The
DuPont Merck Pharmaceutical Company, The
Wilmington, DE
Other trademarks owned by DuPont Merck Pharmaceutical Company, The
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DON M KERR
G MATHEW LOMBARD BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENEW YORK, NY 10154UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging | SECTION 8 - CANCELLED | Dec 1, 2000 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DUPONT PHARMACEUTICALS COMPANY
- Other trademarks owned by DUPONT PHARMACEUTICALS COMPANY
- Other trademarks owned by DUPONT PHARMACEUTICALS COMPANY
- Other trademarks owned by DUPONT PHARMACEUTICALS COMPANY
- Other trademarks owned by DuPont Merck Pharmaceutical Company, The
- Other trademarks owned by DuPont Merck Pharmaceutical Company, The
- Other trademarks owned by DuPont Merck Pharmaceutical Company, The
- Other trademarks owned by DuPont Merck Pharmaceutical Company, The
- Other trademarks in Class 005
- Similar marks named LUMAXIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 2, 2008 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 14, 2007 | CFIT | CASE FILE IN TICRS | — |
| Jul 24, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 31, 2001 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 21, 2001 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 10, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 7, 2001 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 12, 2000 | IUAF | USE AMENDMENT FILED | — |
| Dec 12, 2000 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 27, 2000 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 12, 2000 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 22, 2000 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 28, 1999 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 2, 1999 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 15, 1999 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 25, 1999 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 10, 1998 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 10, 1998 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 31, 1998 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 6, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 5, 1997 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 11, 1997 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 5, 1997 | DOCK | ASSIGNED TO EXAMINER | — |